Atlas Venture Associates X, L.P. Generation Bio Co. (GBIO) insider trading activity

Atlas Venture Associates X, L.P. is > 10% Shareholder of Generation Bio Co.. Currently has a direct ownership of 0 shares of GBIO, which is worth approximately $0. The most recent transaction as insider was on Sep 29, 2021, when has been sold 16,556 shares (Common Stock) at a price of $24.59 per share, resulting in proceeds of $407,112. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

ATLAS VENTURE ASSOCIATES X, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 29 2021	SELL Open market or private sale	$407,112 $24.59 p/Share	16,556 Reduced 100.0%	0 Common Stock
Sep 28 2021	SELL Open market or private sale	$330,366 $25.24 p/Share	13,089 Reduced 44.15%	16,556 Common Stock
Sep 27 2021	SELL Open market or private sale	$1,318,256 $25.7 p/Share	51,294 Reduced 63.37%	29,645 Common Stock
Sep 24 2021	SELL Open market or private sale	$745,794 $25.84 p/Share	28,862 Reduced 26.29%	80,939 Common Stock
Sep 23 2021	SELL Open market or private sale	$1,984,061 $26.34 p/Share	75,325 Reduced 40.69%	109,801 Common Stock
Sep 22 2021	SELL Open market or private sale	$791,198 $25.89 p/Share	30,560 Reduced 14.17%	185,126 Common Stock
Jun 24 2021	SELL Open market or private sale	$807,176 $26.08 p/Share	30,950 Reduced 100.0%	0 Common Stock
Jun 23 2021	SELL Open market or private sale	$1,586,697 $25.39 p/Share	62,493 Reduced 66.88%	30,950 Common Stock
Jun 22 2021	SELL Open market or private sale	$1,460,556 $24.98 p/Share	58,469 Reduced 38.49%	93,443 Common Stock
Jun 21 2021	SELL Open market or private sale	$1,592,437 $24.97 p/Share	63,774 Reduced 29.57%	151,912 Common Stock
Apr 14 2021	SELL Open market or private sale	$622,552 $26.59 p/Share	23,413 Reduced 100.0%	0 Common Stock
Apr 13 2021	SELL Open market or private sale	$1,092,000 $25.31 p/Share	43,145 Reduced 64.82%	23,413 Common Stock
Apr 12 2021	SELL Open market or private sale	$1,952,426 $26.34 p/Share	74,124 Reduced 52.69%	66,558 Common Stock
Apr 09 2021	SELL Open market or private sale	$1,221,321 $27.96 p/Share	43,681 Reduced 23.69%	140,682 Common Stock
Apr 08 2021	SELL Open market or private sale	$1,249,014 $28.68 p/Share	43,550 Reduced 19.11%	184,363 Common Stock
Apr 07 2021	SELL Open market or private sale	$1,149,678 $28.84 p/Share	39,864 Reduced 14.89%	227,913 Common Stock

Also insider at

KYMR

Kymera Therapeutics, Inc. Healthcare

> 10% Shareholder

AVA